Komori
Share Issuance and Disposal4381BPLATS,Inc.Information and Communications, Services and Others

Notice Regarding the Monthly Exercise Status of the Sixth Series of Stock Acquisition Rights, the First Series of Unsecured Convertible Bonds with Stock Acquisition Rights, and the Seventh Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause)

In October 2026, 2,910 Series 7 Stock Acquisition Rights were exercised and 291,000 shares were delivered. No Series 6 Stock Acquisition Rights or Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights were exercised.

Worth reading
65In focus
Scored from 3 of 5 sections
Direction
Deterioration
Direction inferred from the company’s description.
Scale
291000
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Series 7 Stock Acquisition Rights (with an exercise price adjustment provision) through a third-party allotment

Who receives how much

291,000 shares delivered upon exercise of the Series 7 Stock Acquisition Rights (291,000 new shares and 0 transferred treasury shares)

GP上場企業出資投資事業有限責任組合 (not identified in the text as the allottee of the Series 7 Stock Acquisition Rights)

The lower thin line represents the existing number of shares to which these shares will be added.

Existing Shares and Increase
+6.28%Rate of increase
4,634,098 shares4,925,098Shares

Approximately 6.28% (291,000 shares / 4,634,098 shares outstanding as of the end of the month preceding the relevant month)

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Terms of the stock acquisition rights
Exercise price
The Series 7 Stock Acquisition Rights have an exercise price adjustment provision. The exercise prices in October 2026 were ¥192, ¥191, ¥278, ¥229, ¥210, ¥197, ¥184 and ¥180. The adjustment floor is Not disclosed
Number of Stock Acquisition Rights
The total number of Series 7 Stock Acquisition Rights is Not disclosed; 2,910 were exercised during the relevant month, and 1,318 remained unexercised at month-end. 8,288 Series 6 Stock Acquisition Rights remained unexercised at month-end
Procedures under the Corporate Code of Conduct
Disclosure of compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments, etc. The number of shares delivered across all series was 291,000, the number of listed shares as of the payment date for the issuance was 2,911,799, and the exercise ratio subject to the exercise restrictions was 10.0%.
Most recent equity financing
Timing 14 April 2025 / Type Series 6 Stock Acquisition Rights and Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights / Amount Not disclosed, Timing 15 June 2026 / Type Series 7 Stock Acquisition Rights (with an exercise price adjustment provision) / Amount Not disclosed
Details of issuance or disposal
ItemDetails
Type of issuance or disposalSeries 7 Stock Acquisition Rights (with an exercise price adjustment provision) through a third-party allotment
Number of shares to be issued or disposed of291,000 shares delivered upon exercise of the Series 7 Stock Acquisition Rights (291,000 new shares and 0 transferred treasury shares)
Intended allotteeGP上場企業出資投資事業有限責任組合 (not identified in the text as the allottee of the Series 7 Stock Acquisition Rights)
Dilution RateApproximately 6.28% (291,000 shares / 4,634,098 shares outstanding as of the end of the month preceding the relevant month)
Total number of issued shares4,634,098 shares (as of the end of the month preceding the relevant month) → 4,925,098 shares (simple calculation)(Approximately 6.28%)
Exercise priceThe Series 7 Stock Acquisition Rights have an exercise price adjustment provision. The exercise prices in October 2026 were ¥192, ¥191, ¥278, ¥229, ¥210, ¥197, ¥184 and ¥180. The adjustment floor is Not disclosed
Number of Stock Acquisition RightsThe total number of Series 7 Stock Acquisition Rights is Not disclosed; 2,910 were exercised during the relevant month, and 1,318 remained unexercised at month-end. 8,288 Series 6 Stock Acquisition Rights remained unexercised at month-end
Procedures under the Corporate Code of ConductDisclosure of compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments, etc. The number of shares delivered across all series was 291,000, the number of listed shares as of the payment date for the issuance was 2,911,799, and the exercise ratio subject to the exercise restrictions was 10.0%.
Most recent equity financingTiming 14 April 2025 / Type Series 6 Stock Acquisition Rights and Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights / Amount Not disclosed, Timing 15 June 2026 / Type Series 7 Stock Acquisition Rights (with an exercise price adjustment provision) / Amount Not disclosed
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Series 6 Stock Acquisition Rights and Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights are deemed “MSCBs, etc.” under the rules of the Tokyo Stock Exchange in connection with the issuance of the Series 7 Stock Acquisition Rights (with an exercise price adjustment provision), and therefore monthly exercise status is disclosed.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Monthly Exercise Status of the Sixth Series of Stock Acquisition Rights, the First Series of Unsecured Convertible Bonds with Stock Acquisition Rights, and the Seventh Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) | BPLATS,Inc. (4381) timely disclosure | Komori